Related Articles
Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: A study of 55 cases
HER2 analysis in breast cancer: Reduced immunoreactivity in FISH non-informative cancer biopsies
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy